Board of Directors


Glycostem has an experienced supervisory board consisting of: 

Jan van der Hoeven, Director

is an investor in the field of Life Sciences. He has more than 25 years of operating, scientific and financial experience in private equity backed life sciences companies. He has been involved in a number of successful international merger & acquisition deals. He is active in a number of funds to stimulate Life Sciences Companies.

Cees de Wolff, Director

is co-owner of De Wolff Verenigde Bedrijven (DWVB), a group of mid-sized companies he and his brother Jan founded in the early nineties after they took over the steel construction family-business. As a new part of the industrial activities, Cees started wind power activities that grew into a large group of very successful wind power companies. After 25 years this De Wolff-Wind-Group has been sold to Dutch utility Eneco in 2017. Since 2004 Cees plays an active role in determining financing, growth and strategic direction of an increasing number of innovative Dutch companies that are active in the field of life-sciences (oncology) and tech. Cees brings 30 years of no-nonsense hands-on business experience and serves as advisor and/or board member in a large number of innovative companies. Prior to the family business Cees has successfully designed and implemented ISO based quality and Shell based safety-systems in mid-sized companies in Holland and in the Far East. Cees holds a Bachelor degree in law and a Master degree in entrepreneurship.

Subscribe to our newsletter

If you subscribe you agree to the Privacy Notice of Glycostem Therapeutics B.V. as found on the website.